Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03225326

Effects of Articaine Computer-controlled and Conventional Delivery for Anterior and Middle Superior Alveolar Nerve Block for Tooth Extraction

Efficacy of Anterior and Middle Superior Alveolar (AMSA) Nerve Block Anesthesia Obtained by Articaine Computer-controlled and Conventional Delivery

Status
Withdrawn
Phase
Phase 4
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of Belgrade · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study was to investigate and compare pulpal anesthesia and cardiovascular parameters obtained with 0.6 ml of 4% articaine with epinephrine (1:100.000) for anterior and middle superior alveolar nerve (AMSA) block performed by standard and computer-controlled delivery for maxillary teeth extraction.

Conditions

Interventions

TypeNameDescription
DRUGComputer controlled 4% articaine delivery by AnaejectSingle dose of 0.6ml 4% articaine with epinephrine (1:100.000) delivered by computer controlled local anesthetic delivery system (Anaeject)
DRUGConventional 4% articaine delivery by carpule syringeSingle dose of 0.6ml 4% articaine with epinephrine (1:100.000) delivered by conventional syringe (carpule syringe).

Timeline

Start date
2016-12-01
Primary completion
2017-06-01
Completion
2017-07-01
First posted
2017-07-21
Last updated
2018-03-22

Locations

1 site across 1 country: Serbia

Source: ClinicalTrials.gov record NCT03225326. Inclusion in this directory is not an endorsement.

Effects of Articaine Computer-controlled and Conventional Delivery for Anterior and Middle Superior Alveolar Nerve Block (NCT03225326) · Clinical Trials Directory